For decades, J.D. Power’s research has been a key tool for savvy consumers trying to separate companies with high-quality products and world-class customer service from the other guys.

Johnson & Johnson (NYSE:JNJ) fell ~3% in early trading on Wednesday, marking its biggest intraday drop since July 2023, even as the healthcare giant posted better-than-expected financials for Q4 ...

J&J said that about a third of adults will not respond to oral antidepressants alone. Sign up here to get The Results Are In with Dr. Sanjay Gupta every Friday from the CNN Health team.

Liz Giuffre does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

The deal would help accelerate growth in J&J's drugs business after the company spun off its consumer health unit in 2023. It has made several transactions in the past few years to boost its ...

A unit of Gamuda—a construction company cofounded by Malaysian tycoon Lin Yun Ling—won an 8.3 billion ringgit contract ($1.8 billion) to design and build a commuter railway project in the ...

You now have the opportunity to own a piece of Naim's hi-fi history at a reduced price. The British brand launched the Nait 50 stereo amplifier in mid-2023 as part of its 50th-anniversary celebrations ...

David joined Raw Story in 2023 after nearly a decade of writing about the legal industry for Bloomberg Law. He is also a co-founder and a commissioning editor at Hypatia Press, a publisher that ...

In a major move set to electrify action film aficionados, Shout! Studios has nabbed worldwide rights (excluding select Asian territories) to the coveted Golden Princess movie library, a treasure ...

J&J's $132 per-share offer implies 39% premium Deal could kick off spree of activity in sector in 2025 CEO says such large deals not common The deal would help accelerate growth in J&J's drugs ...